home / lobbying / lobbying_activities

lobbying_activities: 1807476

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1807476 2582a572-f6cd-41ea-8e58-10433d1db351 Q1 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2016 first_quarter PHA National Defense Authorization Act of FY 2017 - Work to ensure that the current treatment of mail order for retired and active military personnel and their families remains constant in the pending Authorization bill. The Comprehensive Addiction and Recovery Act(S. 524) - Legislation focused on fighting the opioid epidemic in America, including amendments allowing the use of certain pharmacies and providers to protect Medicare beneficiaries from addiction. The Mental Health Reform Act of 2015 (S. 1945) - Legislation focused on improving treatment for mental health and substance use disorders. Particular focus on formulary policies. FDA's March 31, 2016 biosimilar labeling guidance and additional work regarding biosimilars. Implementation of the health reform law with a focus on policies and regulations related to biosimilars, prescription drug coverage in the Exchanges and related policies. Policies related to Medicare Part C and D with a focus on network design, formularies and access to specialty medications. Issues related to mail order coverage for Medicare, Medicaid, Exchanges, Tricare and other programs. Issues related to the pricing of prescription medications. Rules, regulations, guidance and potential legislation specific to prescription drug pricing, generic utilization, biosimilars medications and specialty pharmacy. Issues related to the treatment of pharmacy benefit managers in federal programs. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Issues related to access and affordability for prescription medications for both government and private sector benefit programs. H.R. 1735 - National Defense Authorization Act for Fiscal Year 2016 - issues related to prescription drug coverage options for retired and active military personnel. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2016-04-14T12:51:48.827000-04:00
Powered by Datasette · Queries took 0.745ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API